
Jennifer E. Graser
Examiner (ID: 2460)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1802, 1645, 1641, 1621 |
| Total Applications | 1924 |
| Issued Applications | 1280 |
| Pending Applications | 238 |
| Abandoned Applications | 464 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17748191
[patent_doc_number] => 20220226394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/576339
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17576339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/576339 | ALGORIPHAGUS SP, BOSEA SP, BREVUNDIMONAS SP, DESULFOVIBRIO SP, MICROBACTERIUM SP, SPHINGOMONAS SP, AND VARIOVORAX SP FOR USE IN DISEASE PREVENTION AND TREATMENT | Jan 13, 2022 | Pending |
Array
(
[id] => 19032563
[patent_doc_number] => 20240082378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines
[patent_app_type] => utility
[patent_app_number] => 18/261568
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261568
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261568 | Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines | Jan 13, 2022 | Pending |
Array
(
[id] => 19032563
[patent_doc_number] => 20240082378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines
[patent_app_type] => utility
[patent_app_number] => 18/261568
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261568
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261568 | Staphylococcus aureus Antigen-Based Nucleic Acid Vaccines | Jan 13, 2022 | Pending |
Array
(
[id] => 18986462
[patent_doc_number] => 20240058431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => NOVEL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/270947
[patent_app_country] => US
[patent_app_date] => 2022-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270947
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270947 | NOVEL COMPOSITION | Jan 4, 2022 | Pending |
Array
(
[id] => 18953627
[patent_doc_number] => 20240041954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS
[patent_app_type] => utility
[patent_app_number] => 18/259014
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18259014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/259014 | USE OF LACTIC ACID BACTERIA TO INHIBIT METHANOGEN GROWTH OR REDUCE METHANE EMISSIONS | Dec 21, 2021 | Pending |
Array
(
[id] => 18953674
[patent_doc_number] => 20240042001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 18/258842
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | Dec 20, 2021 | Pending |
Array
(
[id] => 18953674
[patent_doc_number] => 20240042001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII
[patent_app_type] => utility
[patent_app_number] => 18/258842
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258842 | IRRADIATED WHOLE-CELL IMMUNOGENS OF ACINETOBACTER BAUMANNII | Dec 20, 2021 | Pending |
Array
(
[id] => 17671029
[patent_doc_number] => 20220184196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/556294
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556294 | Methods and compositions for treating and diagnosing autoimmune diseases | Dec 19, 2021 | Issued |
Array
(
[id] => 17671029
[patent_doc_number] => 20220184196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/556294
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17556294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/556294 | Methods and compositions for treating and diagnosing autoimmune diseases | Dec 19, 2021 | Issued |
Array
(
[id] => 17704573
[patent_doc_number] => 20220204579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS OF PRODUCING AGGREGATE-FREE MONOMERIC DIPHTHERIA TOXIN FUSION PROTEINS AND THERAPEUTIC USES
[patent_app_type] => utility
[patent_app_number] => 17/549845
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549845
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549845 | Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses | Dec 12, 2021 | Issued |
Array
(
[id] => 17704573
[patent_doc_number] => 20220204579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => METHODS OF PRODUCING AGGREGATE-FREE MONOMERIC DIPHTHERIA TOXIN FUSION PROTEINS AND THERAPEUTIC USES
[patent_app_type] => utility
[patent_app_number] => 17/549845
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549845
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549845 | Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses | Dec 12, 2021 | Issued |
Array
(
[id] => 17640671
[patent_doc_number] => 20220168409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => VACCINES
[patent_app_type] => utility
[patent_app_number] => 17/644019
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644019
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/644019 | Vaccines | Dec 12, 2021 | Issued |
Array
(
[id] => 18893816
[patent_doc_number] => 20240009301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => IMMUNOGENIC COMPOSITIONS FOR PRODUCING NEUTRALISING ANTIBODIES AGAINST SARS-COV
[patent_app_type] => utility
[patent_app_number] => 18/265081
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265081
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265081 | IMMUNOGENIC COMPOSITIONS FOR PRODUCING NEUTRALISING ANTIBODIES AGAINST SARS-COV | Dec 2, 2021 | Pending |
Array
(
[id] => 17748243
[patent_doc_number] => 20220226446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/457369
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/457369 | NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION | Dec 1, 2021 | Abandoned |
Array
(
[id] => 17611856
[patent_doc_number] => 20220154135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Live Attenuated Non-Transmissible Vaccines
[patent_app_type] => utility
[patent_app_number] => 17/532784
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532784 | Live Attenuated Non-Transmissible Vaccines | Nov 21, 2021 | Pending |
Array
(
[id] => 18634858
[patent_doc_number] => 11759429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Vaccine delivery systems using yeast cell wall particles
[patent_app_type] => utility
[patent_app_number] => 17/532656
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 11923
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532656 | Vaccine delivery systems using yeast cell wall particles | Nov 21, 2021 | Issued |
Array
(
[id] => 17457954
[patent_doc_number] => 20220071258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => Composition and Method for Germinative Compounds in Probiotic Food and Beverage Products for Human Consumption
[patent_app_type] => utility
[patent_app_number] => 17/530731
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17530731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/530731 | Composition and method for germinative compounds in probiotic food and beverage products for human consumption | Nov 18, 2021 | Issued |
Array
(
[id] => 18931081
[patent_doc_number] => 11883475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Infectious
[patent_app_type] => utility
[patent_app_number] => 17/529812
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 9834
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529812
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529812 | Infectious | Nov 17, 2021 | Issued |
Array
(
[id] => 17482123
[patent_doc_number] => 20220089627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/528426
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528426 | STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES | Nov 16, 2021 | Abandoned |
Array
(
[id] => 18893017
[patent_doc_number] => 20240008502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => LACTIC ACID BACTERIAL STRAIN WITH IMPROVED TEXTURIZING PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 18/253180
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7836
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253180 | LACTIC ACID BACTERIAL STRAIN WITH IMPROVED TEXTURIZING PROPERTIES | Nov 15, 2021 | Pending |